SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-029414
Filing Date
2015-05-11
Accepted
2015-05-11 17:21:10
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v408078_10q.htm 10-Q 256340
2 EXHIBIT 31.1 v408078_ex31-1.htm EX-31.1 8551
3 EXHIBIT 32.1 v408078_ex32-1.htm EX-32.1 4094
  Complete submission text file 0001144204-15-029414.txt   4421912

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20150331.xml EX-101.INS 507582
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20150331.xsd EX-101.SCH 63931
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20150331_cal.xml EX-101.CAL 34389
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20150331_def.xml EX-101.DEF 349529
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20150331_lab.xml EX-101.LAB 373088
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20150331_pre.xml EX-101.PRE 382652
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 15851873
SIC: 2834 Pharmaceutical Preparations